Related Experiment Video
Updated: Aug 14, 2026

Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions
Published on: October 21, 2017
Microglia response and P2 receptor participation in oxygen/glucose deprivation-induced cortical damage
F Cavaliere1, K Dinkel, K Reymann
1Research Institute for Applied Neuroscience, FAN GmbH, Leipziger Str., 44, D-39120 Magdeburg, Germany. f.cavaliere@nsantalucia.it
Abstract:
In the present work, we used a unique cortical/striatal/subventricular zone organotypic model in order to analyze the role of resident microglia in oxygen/glucose deprivation and to check the presence and modulation of several P2 receptors in the cortex. Immunofluorescence with the microglial marker OX42 and pharmacological experiments with indomethacin indicate that activation and recruitment of microglia after the insult is linked to cellular loss, mainly in the cortex. The confocal analysis with OX42 shows that, among the P2 receptors tested, P2X4, and P2X7 are expressed on microglia, while P2X1 and P2Y(1-2-12), although present in the slices, did not co-localize, whereas P2X6 is not detected. The upregulation of P2X4 and P2X7 on microglia and the toxic effect that different P2 agonists exert on cortical slices during oxygen/glucose deprivation indicate that a purinergic mechanism is related to the microglia activity; the protective effect of the P2 antagonist TNP-ATP is also described. In order to better understand the relationship between P2 receptors and OGD-activated microglia, we induced oxygen/glucose deprivation in co-cultures of organotypic slices and N9 microglia cell line. The presence of the N9 (which expresses P2X4 and P2X7 protein) in the cultures increases the damage in the cortex by 40% and the use of P2 antagonist PPADS reduced the cell damage due to the N9 activation. Our results show that microglia recruitment after a metabolic impairment is associated with cellular loss and that P2X4 and P2X7, are involved in microglia activity. The neuroprotective action exerted by TNP-ATP and PPADS and the possible use of purinergic antagonist in the pharmacological treatment of oxygen/glucose deprivation is also addressed.
Insights
Resident microglia and P2X4/P2X7 receptors contribute to brain damage after oxygen/glucose deprivation. Purinergic antagonists like TNP-ATP and PPADS show neuroprotective effects, suggesting potential therapeutic applications.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Microglia, the resident immune cells of the brain, play a critical role in neuroinflammation.
- Oxygen/glucose deprivation (OGD) is a major cause of ischemic stroke and neuronal damage.
- P2 receptors are involved in cellular signaling and immune responses.
Purpose of the Study:
- To investigate the role of microglia in OGD-induced brain injury.
- To identify the expression and modulation of P2 receptors on microglia during OGD.
- To explore the therapeutic potential of P2 receptor antagonists.
Main Methods:
- Organotypic cortical/striatal/subventricular zone slice model.
- Immunofluorescence staining with microglial marker OX42.
- Pharmacological treatments with P2 agonists and antagonists (indomethacin, TNP-ATP, PPADS).
- Co-culture experiments with N9 microglia cell line.
Main Results:
- Microglia activation and recruitment correlate with cellular loss in the cortex after OGD.
- P2X4 and P2X7 receptors are expressed on microglia and upregulated during OGD.
- P2 agonists exacerbate OGD-induced damage, while antagonists TNP-ATP and PPADS show neuroprotection.
- Co-culturing with N9 microglia increased cortical damage, which was reduced by PPADS.
Conclusions:
- Microglia activation and P2X4/P2X7 receptor signaling contribute to OGD-induced neurotoxicity.
- Purinergic antagonists demonstrate neuroprotective effects, indicating a potential therapeutic strategy for OGD-related conditions.

